Drugs / recombinant C1 inhibitor
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01035593 | Dec 2010 → Dec 2011 | transplant rejection | Pharming Technologies B.V. | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant C1 inhibitor | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01035593 ↗ |
| Route | Intravenous | “100units/kg IV for seven consecutive days” NCT01035593 ↗ |